Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised

Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes

Journey towards a roadmap for regulatory guidance on real-world evidence

Human medicines European public assessment report (EPAR): Litak, cladribine, Date of authorisation: 14/04/2004, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised

Clinical Trials Information System designated as WHO primary registry

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 18 February 2025, 09:30 (CET) to 18 February 2025, 13:00 (CET)

EMEA-002565-PIP02-19-M01